Latest Breaking News On - Inhibikase therapeutic second quarter - Page 1 : comparemela.com

Inhibikase Therapeutics, Inc. (NASDAQ:NASDAQ:IKT) Q2 2022 Earnings Conference Call August 15, 2022 8:00 a.m.

Joe frattaroliAlex loboJoseph frattaroliSoumit royDanya benMilton wernerMovement disorder society congressInhibikase therapeutics incJones researchUs food and drug administrationInhibikase therapeuticsConference call augustInhibikase therapeutic second quarterResults conferenceStern investorChief executive officer